Publications

• Introducing a novel sub-millimeter lung CT image registration error quantitation tool.
  Med Phys Volume: 52 Page(s): 1601 - 1614
  03/01/2025 Authors: Boyle P; Naumann L; Lauria M; Miller C; Andosca R; Savjani R; O'Connell D; Moghanaki D; Barjaktarevic I; Goldin J
• Comment on Wu et al's article on toxicity in patients receiving radiotherapy for ultracentral stage I non-small cell lung cancer.
  Radiother Oncol Volume: 206 Page(s): 110805
  02/22/2025 Authors: Huertas A; Moghanaki D; Siva S
• The association of azole antifungals with overall survival in patients with non-small cell lung cancer receiving immune checkpoint inhibitors.
  Oncologist Volume: 30
  02/06/2025 Authors: Sebastian NT; Stokes WA; Behera M; Jiang R; Gutman DA; Huang Z; Burns A; Sukhatme V; Lowe MC; Ramalingam SS
• A Retrospective Analysis of the First Clinical 5DCT Workflow.
  Cancers (Basel) Volume: 17
  02/05/2025 Authors: Lauria M; Kim M; O'Connell D; Lao Y; Miller CR; Naumann L; Boyle P; Raldow A; Lee A; Savjani RR
• National Survey of Lung Cancer Screening Eligibility in United States Veterans.
  Am J Prev Med
  01/27/2025 Authors: Lewis JA; Stranick A; Pennings J; Samuels LR; Byerly S; Helton J; Park D; Winter R; Matheny ME; Henschke CI
• Centralized Quality Assurance of Stereotactic Body Radiation Therapy for the Veterans Affairs Cooperative Studies Program Study Number 2005: A Phase 3 Randomized Trial of Lung Cancer Surgery or Stereotactic Radiotherapy for Operable Early-Stage Non-Small Cell Lung Cancer (VALOR).
  Pract Radiat Oncol Volume: 15 Page(s): e29 - e39
  01/01/2025 Authors: Ritter TA; Timmerman RD; Hanfi HI; Shi H; Leiner MK; Feng H; Skinner VL; Robin LM; Odle C; Amador G
• Letter to the Editor in Response to "Adherence to Annual Lung Cancer Screening in a Centralized Academic Program".
  Clin Lung Cancer Volume: 25 Page(s): e457 - e458
  12/01/2024 Authors: Wu J; Thomas T; Tavalire HF; Vecchio F; Kyriakides TC; Crothers K; Kelley MJ; Moghanaki D; Shofer S; Hendler F
• Lung cancer-a one-way ticket.
  JNCI Cancer Spectr Volume: 8
  11/01/2024 Authors: Moghanaki D; Eala MA; Feldman J; DiJulio TA; Gorayski P
• The History and Future of Multidisciplinary Cancer Care.
  Semin Radiat Oncol Volume: 34 Page(s): 441 - 451
  10/01/2024 Authors: LaVigne AW; Doss VL; Berizzi D; Johnston FM; Kiess AP; Kirtane KS; Moghanaki D; Roumeliotis M; Yang GQ; Viswanathan AN
• Evaluation of chest CT-scans following lung stereotactic ablative radiotherapy: Challenges and new insights.
  Lung Cancer Volume: 193 Page(s): 107848
  07/01/2024 Authors: De Bruycker A; Schneiders F; Gulstene S; Moghanaki D; Louie A; Palma D; Senan S
• Pathophysiology and Management of Chest Wall Pain after Surgical and Non-Surgical Local Therapies for Lung Cancer.
  JTO Clin Res Rep Volume: 5 Page(s): 100690
  07/01/2024 Authors: Nikitas J; Yanagawa J; Sacks S; Hui EK; Lee A; Deng J; Abtin F; Suh R; Lee JM; Toste P
• Lung Cancer Survival Trends in the Veterans Health Administration.
  Clin Lung Cancer Volume: 25 Page(s): 225 - 232
  05/01/2024 Authors: Moghanaki D; Taylor J; Bryant AK; Vitzthum LK; Sebastian N; Gutman D; Burns A; Huang Z; Lewis JA; Spalluto LB
• Salvage percutaneous high-dose-rate brachyablation after stereotactic body radiation therapy for early-stage non-small cell lung cancer.
  J Contemp Brachytherapy Volume: 16 Page(s): 150 - 155
  04/01/2024 Authors: Wu TC; Lee A; Suh R; Oughourlian TC; Abtin F; Hagio MA; Park S-J; Chang AJ; Moghanaki D
• Pneumonitis After Chemoradiotherapy and Adjuvant Durvalumab in Stage III Non-Small Cell Lung Cancer.
  Int J Radiat Oncol Biol Phys Volume: 118 Page(s): 963 - 970
  03/15/2024 Authors: Edwards DM; Sankar K; Alseri A; Jiang R; Schipper M; Miller S; Dess K; Strohbehn GW; Elliott DA; Moghanaki D
• Sub-lobar resections for peripheral non-small cell lung cancer measuring2cm: Insights from recent clinical trials.
  Radiother Oncol Volume: 192 Page(s): 110094
  03/01/2024 Authors: Senan S; Schneiders FL; Moghanaki D
• MR-LINAC, a New Partner in Radiation Oncology: Current Landscape.
  Cancers (Basel) Volume: 16
  01/08/2024 Authors: Ocanto A; Torres L; Montijano M; Rincn D; Fernndez C; Sevilla B; Gonsalves D; Teja M; Guijarro M; Glara L
• The Association of Organizational Readiness With Lung Cancer Screening Utilization.
  Am J Prev Med Volume: 65 Page(s): 844 - 853
  11/01/2023 Authors: Lewis JA; Samuels LR; Weems J; Park D; Winter R; Lindsell CJ; Callaway-Lane C; Audet C; Slatore CG; Wiener RS
• Unresectable Stage III NSCLC Should Not be Treated With Neoadjuvant Therapy and Re-Evaluated for Resection.
  J Thorac Oncol Volume: 18 Page(s): 1129 - 1133
  09/01/2023 Authors: Moghanaki D; Lisberg A; Oh S; Lee JM
• Predicting Overall Survival for Patients with Malignant Mesothelioma Following Radiotherapy via Interpretable Machine Learning.
  Cancers (Basel) Volume: 15
  08/01/2023 Authors: Wang Z; Li VR; Chu F-I; Yu V; Lee A; Low D; Moghanaki D; Lee P; Qi XS
• The Association of Improved Overall Survival with NSAIDs in Non-Small Cell Lung Cancer Patients Receiving Immune Checkpoint Inhibitors.
  Clin Lung Cancer Volume: 24 Page(s): 287 - 294
  05/01/2023 Authors: Sebastian NT; Stokes WA; Behera M; Jiang R; Gutman DA; Huang Z; Burns A; Sukhatme V; Lowe MC; Ramalingam SS
• Brief Report: Severe Pneumonitis After Combined Thoracic Radiotherapy and Osimertinib.
  JTO Clin Res Rep Volume: 4 Page(s): 100468
  03/01/2023 Authors: Smith CP; Xiang M; Yoon SM; Lee A; Ruan D; Goldman JW; Cummings AL; Lisberg A; Garon EB; Moghanaki D
• Using the Framework for Reporting Adaptations and Modifications-Expanded (FRAME) to study adaptations in lung cancer screening delivery in the Veterans Health Administration: a cohort study.
  Implement Sci Commun Volume: 4 Page(s): 5
  01/12/2023 Authors: Strayer TE; Spalluto LB; Burns A; Lindsell CJ; Henschke CI; Yankelevitz DF; Moghanaki D; Dittus RS; Vogus TJ; Audet C
• Impact of concomitant fibrates on immunotherapy outcomes for advanced non-small cell lung cancer.
  Cancer Med Volume: 12 Page(s): 358 - 367
  01/01/2023 Authors: Stokes WA; Behera M; Jiang R; Gutman DA; Huang Z; Burns A; Sebastian NT; Sukhatme V; Lowe MC; Ramalingam SS
• Rural barriers and facilitators of lung cancer screening program implementation in the veterans health administration: a qualitative study.
  Front Health Serv Volume: 3 Page(s): 1209720
  01/01/2023 Authors: Lewis JA; Bonnet K; Schlundt DG; Byerly S; Lindsell CJ; Henschke CI; Yankelevitz DF; York SJ; Hendler F; Dittus RS
• Sins of omission: A meta-research study evaluating the omission of operability in published retrospective comparisons of surgery with stereotactic body radiotherapy in patients with early-stage non-small cell lung cancer.
  Lung Cancer Volume: 175 Page(s): 57 - 59
  01/01/2023 Authors: Lorenz J; Moghanaki D; Keshava H; Harpole DH; Bradley JD; Higgins KA; Rusthoven CG; Stokes WA
• Outcomes following radical prostatectomy or external beam radiation for veterans with Gleason 9 and 10 prostate cancer.
  Cancer Med Volume: 11 Page(s): 2886 - 2895
  08/01/2022 Authors: Chao H-H; Soni PD; Dahman B; Stilianoudakis SC; Ford H; Singh R; Freedland SJ; Moghanaki D; Vapiwala N; Chang MG
• De-escalating adjuvant durvalumab treatment duration in stage III non-small cell lung cancer.
  Eur J Cancer Volume: 171 Page(s): 55 - 63
  08/01/2022 Authors: Bryant AK; Sankar K; Zhao L; Strohbehn GW; Elliott D; Moghanaki D; Kelley MJ; Ramnath N; Green MD
• Association of Operability With Post-Treatment Mortality in Early-Stage Non-Small Cell Lung Cancer.
  Clin Lung Cancer Volume: 23 Page(s): e231 - e237
  05/01/2022 Authors: Stokes WA; Xiong N; Liu Y; Higgins KA; Tian S; Bradley JD; Moghanaki D; Rusthoven CG
• Development of a new adapted QuinteT Recruitment Intervention (QRI-Two) for rapid application to RCTs underway with enrolment shortfalls-to identify previously hidden barriers and improve recruitment.
  Trials Volume: 23 Page(s): 258
  04/04/2022 Authors: Donovan JL; Jepson M; Rooshenas L; Paramasivan S; Mills N; Elliott D; Wade J; Reda D; Blazeby JM; Moghanaki D
• Surgical Outcomes for Early Stage Non-small Cell Lung Cancer at Facilities With Stereotactic Body Radiation Therapy Programs.
  Chest Volume: 161 Page(s): 833 - 844
  03/01/2022 Authors: Syed YA; Stokes W; Rupji M; Liu Y; Khullar O; Sebastian N; Higgins K; Bradley JD; Curran WJ; Ramalingam S
• Performing SBRT in the Fly-With-Caution Zone: Are We Heeding the Advice of Daedalus?
  Int J Radiat Oncol Biol Phys Volume: 112 Page(s): 586 - 589
  03/01/2022 Authors: Swaminath A; Ritter T; Louie AV; Palma DA; Guckenberger M; Senan S; Bezjak A; Moghanaki D
• Real World Outcomes versus Clinical Trial Results of Durvalumab Maintenance in Veterans with Stage III Non-Small Cell Lung Cancer.
  Cancers (Basel) Volume: 14
  01/26/2022 Authors: Sankar K; Bryant AK; Strohbehn GW; Zhao L; Elliott D; Moghanaki D; Kelley MJ; Ramnath N; Green MD
• Association of Rurality With Annual Repeat Lung Cancer Screening in the Veterans Health Administration.
  J Am Coll Radiol Volume: 19 Page(s): 131 - 138
  01/01/2022 Authors: Spalluto LB; Lewis JA; Samuels LR; Callaway-Lane C; Matheny ME; Denton J; Robles JA; Dittus RS; Yankelevitz DF; Henschke CI
• Characterizing Twitter Influencers in Radiation Oncology.
  Adv Radiat Oncol Volume: 7 Page(s): 100919
  01/01/2022 Authors: Valle LF; Chu F-I; Smith M; Wang C; Lee P; Moghanaki D; Chino FL; Steinberg ML; Raldow AC
• Toxicity Outcomes After Low-Dose-Rate vs. High-Dose-Rate Brachytherapy Boost in Combination With External Beam Radiation for Intermediate and High-Risk Prostate Cancer.
  Int J Radiat Oncol Biol Phys Volume: 111 Page(s): e272
  11/01/2021 Authors: Dhere VR; Fischer-Valuck BW; Goyal S; Liu Y; Morgan T; Ghavidel B; Moghanaki D; Hershatter B; Patel PR; Jani A
• Outcomes with multi-disciplinary management of central lung tumors with CT-guided percutaneous high dose rate brachyablation.
  Radiat Oncol Volume: 16 Page(s): 99
  06/01/2021 Authors: Yoon SM; Suh R; Abtin F; Moghanaki D; Genshaft S; Kamrava M; Drakaki A; Liu S; Venkat P; Lee A
• Organizational Readiness for Lung Cancer Screening: A Cross-Sectional Evaluation at a Veterans Affairs Medical Center.
  J Am Coll Radiol Volume: 18 Page(s): 809 - 819
  06/01/2021 Authors: Spalluto LB; Lewis JA; Stolldorf D; Yeh VM; Callaway-Lane C; Wiener RS; Slatore CG; Yankelevitz DF; Henschke CI; Vogus TJ
• Protocol to evaluate an enterprise-wide initiative to increase access to lung cancer screening in the Veterans Health Administration.
  Clin Imaging Volume: 73 Page(s): 151 - 161
  05/01/2021 Authors: Lewis JA; Spalluto LB; Henschke CI; Yankelevitz DF; Aguayo SM; Morales P; Avila R; Audet CM; Prusaczyk B; Lindsell CJ
• The Regimen of Computed Tomography Screening for Lung Cancer: Lessons Learned Over 25 Years From the International Early Lung Cancer Action Program.
  J Thorac Imaging Volume: 36 Page(s): 6 - 23
  01/01/2021 Authors: Henschke CI; Yip R; Shaham D; Zulueta JJ; Aguayo SM; Reeves AP; Jirapatnakul A; Avila R; Moghanaki D; Yankelevitz DF
• Influence of Timing Between Androgen Deprivation Therapy and External Beam Radiation Therapy in Patients With Localized, High-Risk Prostate Cancer.
  Adv Radiat Oncol Volume: 6 Page(s): 100803
  01/01/2021 Authors: McCall NS; Liu Y; Patel SA; Hershatter B; Moghanaki D; Godette KD; Hanasoge S; Patel P; Fischer-Valuck BW; Shelton JW
• An International Expert Survey on the Indications and Practice of Radical Thoracic Reirradiation for Non-Small Cell Lung Cancer.
  Adv Radiat Oncol Volume: 6 Page(s): 100653
  01/01/2021 Authors: Rulach R; Ball D; Chua KLM; Dahele M; De Ruysscher D; Franks K; Gomez D; Guckenberger M; Hanna GG; Louie AV
• Use and Outcomes of SBRT for Early Stage NSCLC Without Pathologic Confirmation in the Veterans Health Care Administration.
  Adv Radiat Oncol Volume: 6 Page(s): 100707
  01/01/2021 Authors: Wilkie JR; Lipson R; Johnson MC; Williams C; Moghanaki D; Elliott D; Owen D; Atluri N; Jolly S; Chapman CH
• Patient-reported outcomes after Low-dose-rate versus High-dose-rate brachytherapy boost in combination with external beam radiation for intermediate and high risk prostate cancer.
  Brachytherapy Volume: 20 Page(s): 1130 - 1138
  01/01/2021 Authors: Dhere VR; Fischer-Valuck BW; Goyal S; Liu Y; Morgan TM; Ghavidel E; Moghanaki DM; Hershatter BW; Patel PR; Jani AB
• Analysis of Radiation Facility Volume and Survival in Men With Lymph Node-Positive Prostate Cancer Treated With Radiation and Androgen Deprivation Therapy.
  JAMA Netw Open Volume: 3 Page(s): e2025143
  12/01/2020 Authors: Patel SA; Goyal S; Liu Y; Moghanaki D; Patel PR; Hanasoge S; Dhere VR; Shelton JW; Godette KD; Jani AB
• Prophylactic cranial irradiation or MRI surveillance for extensive stage small cell lung cancer.
  J Thorac Dis Volume: 12 Page(s): 6225 - 6233
  10/01/2020 Authors: Taylor JM; Rusthoven CG; Moghanaki D
• Longitudinal Health-related Quality of Life among Individuals Considering Treatment for Stage I Non-Small-Cell Lung Cancer.
  Ann Am Thorac Soc Volume: 17 Page(s): 988 - 997
  08/01/2020 Authors: Nugent SM; Golden SE; Hooker ER; Sullivan DR; Thomas CR; Deffebach ME; Sukumar MS; Schipper PH; Tieu BH; Moghanaki D
• Alternative Multidisciplinary Management Options for Locally Advanced NSCLC During the Coronavirus Disease 2019 Global Pandemic.
  J Thorac Oncol Volume: 15 Page(s): 1137 - 1146
  07/01/2020 Authors: Kumar S; Chmura S; Robinson C; Lin SH; Gadgeel SM; Donington J; Feliciano J; Stinchcombe TE; Werner-Wasik M; Edelman MJ
• Assessing the Variability and Quality of Lung Stereotactic Radiation Therapy Treatment Plans Using a Web-Based Crowdsourcing Platform.
  Pract Radiat Oncol Volume: 10 Page(s): e118 - e127
  01/01/2020 Authors: Moghanaki D; Slotman B; Swaminath A; Nelms B; Wang B
• Rectal spacing, prostate coverage, and periprocedural outcomes after hydrogel spacer injection during low-dose-rate brachytherapy implantation.
  Brachytherapy Volume: 19 Page(s): 228 - 233
  01/01/2020 Authors: Kahn J; Dahman B; McLaughlin C; Kapoor P; Kapoor R; Harris E; Sharma M; Schutzer M; Moghanaki D
• Authors' response.
  Brachytherapy Volume: 19 Page(s): 555
  01/01/2020 Authors: Kahn JM; Moghanaki D
• Moderately Hypofractionated Intensity Modulated Radiation Therapy With Simultaneous Integrated Boost for Prostate Cancer: Five-Year Toxicity Results From a Prospective Phase I/II Trial.
  Front Oncol Volume: 10 Page(s): 1686
  01/01/2020 Authors: Ricco A; Mukhopadhyay N; Deng X; Holdford D; Skinner V; Saraiya S; Moghanaki D; Anscher MS; Chang MG
• Validity of the National Death Index to ascertain the date and cause of death in men having undergone prostatectomy for prostate cancer.
  Prostate Cancer Prostatic Dis Volume: 22 Page(s): 633 - 635
  12/01/2019 Authors: Moghanaki D; Howard LE; De Hoedt A; Aronson WJ; Kane CJ; Amling CL; Cooperberg MR; Terris MK; Freedland SJ
• Local consolidative therapy for oligometastatic patients with stage IV non-small cell lung cancer may improve survival, but unanswered questions remain.
  Transl Lung Cancer Res Volume: 8 Page(s): S407 - S411
  12/01/2019 Authors: Pacheco JM; Moghanaki D
• The current and future landscape of radiotherapy for lung cancer.
  Transl Lung Cancer Res Volume: 8 Page(s): S122 - S123
  09/01/2019 Authors: Louie AV; Bahig H; Moghanaki D
• NEOADJUVANT CRYOTHERAPY IMPROVES DYSPHAGIA AND INCREASES REMISSION RATES IN ADVANCED ESOPHAGEAL CANCER
  Volume: 89 Page(s): AB93 - AB93
  06/01/2019 Authors: Shah TU; Kushnir V; Mutha PR; Gill MM; Patel BB; Schutzer M; Moghanaki D; Smallfield G; Patel M; Zfass AM
• Trends in Management of Oligometastatic Hormone-Sensitive Prostate Cancer.
  Curr Oncol Rep Volume: 21 Page(s): 43
  03/27/2019 Authors: Kothari G; Ost P; Cheung P; Blanchard P; Tree AC; van As NJ; Lo SS; Moghanaki D; Loblaw A; Siva S
• Safeguarding Autonomy of Patients With Bladder Cancer.
  Int J Radiat Oncol Biol Phys Volume: 103 Page(s): 81 - 83
  01/01/2019 Authors: Yerramilli D; Moghanaki DM; Efstathiou JA
• Quality Improvements of Veterans Health Administration Radiation Oncology Services Through Partnership for Accreditation With the ACR.
  J Am Coll Radiol Volume: 15 Page(s): 1732 - 1737
  12/01/2018 Authors: Kapoor R; Moghanaki D; Rexrode S; Monzon B; Ray M; Hulick PR; Albuquerque K; Rosenthal SA; Palta JR; Hagan MP
• Comparative Effectiveness of Prostatectomy and Radiation Therapy (RT) in Gleason 9-10 Prostate Cancer
  Volume: 102 Page(s): S147 - S147
  11/01/2018 Authors: Soni PD; Stilianoudakis SC; Dahman B; Chang MG; Vapiwala N; Moghanaki D
• Collaborating to assess the role of stereotactic body radiation therapy in medically operable stage I non-small cell lung cancer.
  J Thorac Dis Volume: 10 Page(s): S3311 - S3313
  09/01/2018 Authors: Cornwell LD; Moghanaki D
• Multi-institutional Evaluation of Elective Nodal Irradiation and/or Androgen Deprivation Therapy with Postprostatectomy Salvage Radiotherapy for Prostate Cancer.
  Eur Urol Volume: 74 Page(s): 99 - 106
  07/01/2018 Authors: Ramey SJ; Agrawal S; Abramowitz MC; Moghanaki D; Pisansky TM; Efstathiou JA; Michalski JM; Spratt DE; Hearn JWD; Koontz BF
• A Phase II Study to Prevent Radiation-induced Rectal Injury With Lovastatin.
  Am J Clin Oncol Volume: 41 Page(s): 544 - 548
  06/01/2018 Authors: Anscher MS; Chang MG; Moghanaki D; Rosu M; Mikkelsen RB; Holdford D; Skinner V; Grob BM; Sanyal A; Wang A
• Comparison Between Adjuvant and Early-Salvage Postprostatectomy Radiotherapy for Prostate Cancer With Adverse Pathological Features.
  JAMA Oncol Volume: 4 Page(s): e175230
  05/10/2018 Authors: Hwang WL; Tendulkar RD; Niemierko A; Agrawal S; Stephans KL; Spratt DE; Hearn JW; Koontz BF; Lee WR; Michalski JM
• Patient-clinician communication among patients with stage I lung cancer.
  Support Care Cancer Volume: 26 Page(s): 1625 - 1633
  05/01/2018 Authors: Nugent SM; Golden SE; Thomas CR; Deffebach ME; Sukumar MS; Schipper PH; Tieu BH; Moghanaki D; Wisnivesky J; Slatore C
• Management of metastatic spinal cord compression among Veterans Health Administration radiation oncologists.
  Ann Palliat Med Volume: 7 Page(s): 234 - 241
  04/01/2018 Authors: Gutt R; Malhotra S; Jolly S; Moghanaki D; Cheuk AV; Fosmire H; Kelly M; Hoffman-Hogg L; Lutz S; Anscher M
• VALIDITY OF THE NATIONAL DEATH INDEX TO ACCURATELY CODE THE DATE OF DEATH AND DEATHS FROM PROSTATE CANCER, IN MEN HAVING UNDERGONE PROSTATECTOMY
  Volume: 199 Page(s): E308 - E309
  04/01/2018 Authors: Moghanaki D; Howard L; De Hoedt A; Aronson W; Kane C; Amling C; Cooperberg M; Terris M; Freedland S
• Optimal timing of post-prostatectomy radiotherapy for prostate cancer with high-risk pathologic features: A multi-institutional analysis.
  Volume: 36
  02/20/2018 Authors: Hwang WL; Tendulkar RD; Niemierko A; Agrawal S; Stephans KL; Spratt DE; Hearn JWD; Koontz BF; Lee WR; Michalski JM
• The great debate flashes: surgery versus stereotactic body radiotherapy as the primary treatment of early-stage lung cancer.
  Eur J Cardiothorac Surg Volume: 53 Page(s): 295 - 305
  02/01/2018 Authors: Weder W; Moghanaki D; Stiles B; Siva S; Rocco G
• The value of collaboration between thoracic surgeons and radiation oncologists while awaiting evidence in operable stage i non-small cell lung cancer.
  J Thorac Cardiovasc Surg Volume: 155 Page(s): 429 - 431
  01/01/2018 Authors: Moghanaki D; Simone CB; Rimner A; Karas TZ; Donington J; Shirvani SM; Daly M; Videtic GM; Movsas B; ASTRO Evidence-Based Guideline Committee for Stereotactic Body Radiation Therapy (SBRT) for Early-Stage NonSmall Cell Lung Cancer
• Phase 1/2 study of hypofractionated intensity-modulated radiation therapy for prostate cancer including simultaneously integrated boost.
  Pract Radiat Oncol Volume: 8 Page(s): e149 - e157
  01/01/2018 Authors: Chang MG; Mukhopadhyay N; Holdford D; Skinner V; Saraiya S; Moghanaki D; Anscher MS
• Video-assisted thoracoscopic lobectomy is associated with greater recurrence-free survival than stereotactic body radiotherapy for clinical stage I lung cancer.
  J Thorac Cardiovasc Surg Volume: 155 Page(s): 395 - 402
  01/01/2018 Authors: Cornwell LD; Echeverria AE; Samuelian J; Mayor J; Casal RF; Bakaeen FG; Omer S; Preventza O; Mai W; Chen G
• Lung cancer specialists' opinions on treatment for stage I non-small cell lung cancer: A multidisciplinary survey.
  Adv Radiat Oncol Volume: 3 Page(s): 125 - 129
  01/01/2018 Authors: Lammers A; Mitin T; Moghanaki D; Thomas CR; Timmerman R; Golden SE; Thakurta S; Dziadziuszko R; Slatore CG
• Stereotactic Body Radiotherapy for Primary Prostate Cancer.
  Technol Cancer Res Treat Volume: 17 Page(s): 1533033818789633
  01/01/2018 Authors: Kothari G; Loblaw A; Tree AC; van As NJ; Moghanaki D; Lo SS; Ost P; Siva S
• Definitive Stereotactic Body Radiotherapy (SBRT) for Extracranial Oligometastases: An International Survey of >1000 Radiation Oncologists.
  Volume: 40 Page(s): 418 - 422
  08/01/2017 Authors: Lewis SL; Porceddu S; Nakamura N; Palma DA; Lo SS; Hoskin P; Moghanaki D; Chmura SJ; Salama JK
• Seed Localization in MR-Assisted CT-Based LDR Post-Implant Plan
  Volume: 44 Page(s): 3218 - 3218
  06/01/2017 Authors: Kim T; Lee D; Lewis B; Kapoor P; Datsang R; Kim S; Mead N; Schutzer M; Moghanaki D
• Dumping the information bucket: A qualitative study of clinicians caring for patients with early stage non-small cell lung cancer.
  Patient Educ Couns Volume: 100 Page(s): 861 - 870
  05/01/2017 Authors: Golden SE; Thomas CR; Moghanaki D; Slatore CG; Early Stage Lung Cancer Comparative Effectiveness Research Consortium
• Stereotactic body radiation therapy for early-stage non-small cell lung cancer: Executive Summary of an ASTRO Evidence-Based Guideline.
  Pract Radiat Oncol Volume: 7 Page(s): 295 - 301
  01/01/2017 Authors: Videtic GMM; Donington J; Giuliani M; Heinzerling J; Karas TZ; Kelsey CR; Lally BE; Latzka K; Lo SS; Moghanaki D
• Advances in Prostate Cancer Magnetic Resonance Imaging and Positron Emission Tomography-Computed Tomography for Staging and Radiotherapy Treatment Planning.
  Semin Radiat Oncol Volume: 27 Page(s): 21 - 33
  01/01/2017 Authors: Moghanaki D; Turkbey B; Vapiwala N; Ehdaie B; Frank SJ; McLaughlin PW; Harisinghani M
• Lovastatin may reduce the risk of erectile dysfunction following radiation therapy for prostate cancer.
  Acta Oncol Volume: 55 Page(s): 1500 - 1502
  12/01/2016 Authors: Anscher MS; Chang MG; Moghanaki D; Rosu M; Mikkelsen RB; Holdford D; Skinner V; Grob BM; Sanyal A; Wang A
• Focusing on the "Person" in Personalized Medicine: The Future of Patient-Centered Care in Radiation Oncology.
  J Am Coll Radiol Volume: 13 Page(s): 1571 - 1578
  12/01/2016 Authors: Berman AT; Rosenthal SA; Moghanaki D; Woodhouse KD; Movsas B; Vapiwala N
• Salvage Radiation Therapy Dose Response for Biochemical Failure of Prostate Cancer After Prostatectomy-A Multi-Institutional Observational Study.
  Volume: 96 Page(s): 1046 - 1053
  12/01/2016 Authors: Pisansky TM; Agrawal S; Hamstra DA; Koontz BF; Liauw SL; Efstathiou JA; Michalski JM; Feng FY; Abramowitz MC; Pollack A
• Contemporary Update of a Multi-Institutional Predictive Nomogram for Salvage Radiotherapy After Radical Prostatectomy.
  Volume: 34 Page(s): 3648 - 3654
  10/20/2016 Authors: Tendulkar RD; Agrawal S; Gao T; Efstathiou JA; Pisansky TM; Michalski JM; Koontz BF; Hamstra DA; Feng FY; Liauw SL
• Dosimetric Consequences and Acute Toxicity Following Perirectal Hydrogel Spacer Injection During Permanent Prostate Brachytherapy
  Volume: 96 Page(s): E226 - E226
  10/01/2016 Authors: Kahn J; Kapoor P; Kapoor R; Harris E; Sharma M; Schutzer M; Moghanaki D
• Impact of Race on Treatment and Survival among U.S. Veterans with Early-Stage Lung Cancer.
  J Thorac Oncol Volume: 11 Page(s): 1672 - 1681
  10/01/2016 Authors: Williams CD; Salama JK; Moghanaki D; Karas TZ; Kelley MJ
• In Regard to Valle etal.
  Int J Radiat Oncol Biol Phys Volume: 96 Page(s): 482 - 483
  10/01/2016 Authors: Moghanaki D; Timmerman RD; Slatore CG; Niewoehner DE; Karas TZ
• Lung Cancer Specialists' Opinions on Treatments for Stage I Lung Cancer: A Multidisciplinary Survey
  Volume: 96 Page(s): S172 - S173
  10/01/2016 Authors: Lammers A; Golden S; Thomas CR; Mitin T; Moghanaki D; Timmerman RD; Slatore C
• Benefit of Elective Nodal Irradiation and Androgen Deprivation Therapy with Postprostatectomy Salvage Radiation Therapy for Prostate Cancer
  Volume: 96 Page(s): S102 - S102
  10/01/2016 Authors: Ramey SJ; Abramowitz MC; Moghanaki D; Agrawal S; Efstathiou JA; Pisansky TM; Michalski JM; Koontz BF; Hamstra DA; Feng FY
• Prostate Cancer-Specific Mortality and Survival Outcomes for Salvage Radiation Therapy After Radical Prostatectomy
  Volume: 96 Page(s): S101 - S101
  10/01/2016 Authors: Agrawal S; Stephenson AJ; Michalski J; Efstathiou JA; Pisansky TM; Feng F; Hamstra DA; Koontz BF; Liauw S; Abramowitz MC
• The Effect of Lovastatin on Preservation of Erectile Function After Radiation Therapy (RT) for Prostate Cancer: Secondary Analysis of a Prospective Study
  Volume: 96 Page(s): E261 - E262
  10/01/2016 Authors: Anscher MS; Chang MG; Moghanaki D; Rosu M; Mikkelsen RB; Holdford D; Skinner V; Grob BM; Sanyal A; Mukhopadhyay ND
• Multiparametric Magnetic Resonance Imaging Guided Salvage Low-Dose-Rate Brachytherapy for Locally Recurrent Prostate Cancer-A 15-Year Experience
  Volume: 96 Page(s): E230 - E230
  10/01/2016 Authors: Moghanaki D; Harris E; Urdaneta AI; Williams M; Kapoor P; Yu J; Schutzer M; Chang M; Hagan MP
• Consensus Statement Supporting the Recommendation for Single-Fraction Palliative Radiotherapy for Uncomplicated, Painful Bone Metastases.
  Fed Pract Volume: 33 Page(s): 16S - 22S
  05/01/2016 Authors: Dawson GA; Moghanaki D; Gutt-Garg R; Hoffman-Hgg L; Kelly M; Cheuk A; Fosmire H; Hagan M
• The Availability of Advanced Radiation Oncology Technology within the Veterans Health Administration Radiation Oncology Centers.
  Fed Pract Volume: 33 Page(s): 18S - 22S
  05/01/2016 Authors: Dawson GA; Cheuk AV; Lutz S; Gutt-Garg R; Moghanaki D; Jolly S; Kelly MD; Fosmire H; Hoffman-Hgg L; Kemp W
• Is surgery still the optimal treatment for stage I non-small cell lung cancer?
  Transl Lung Cancer Res Volume: 5 Page(s): 183 - 189
  04/01/2016 Authors: Moghanaki D; Chang JY
• Management of Postprostatectomy Biochemical Relapse With Salvage Radiotherapy: Results of an International Survey.
  Volume: 39 Page(s): 64 - 68
  02/01/2016 Authors: Moghanaki D; Urdaneta AI; Karlin JD; Koontz BF; Anscher MS
• Comparative study of late rectal toxicity in veterans undergoing low-dose rate prostate brachytherapy treated with or without supplemental external beam radiotherapy.
  Volume: 34
  01/10/2016 Authors: Serrano NA; Moghanaki D; Asher D; Karlin J; Schutzer M; Chang MG; Hagan MP
• Phase II study of lovastatin to prevent rectal injury from radiation therapy for prostate cancer.
  Volume: 34
  01/10/2016 Authors: Anscher MS; Chang MG; Moghanaki D; Rosu M; Mikkelsen R; Holdford D; Skinner V; Grob BM; Sanyal AJ; Mukhopadhyay N
• Comparative study of late rectal toxicity in prostate cancer patients treated with low-dose-rate brachytherapy: With or without supplemental external beam radiotherapy.
  Brachytherapy Volume: 15 Page(s): 435 - 441
  01/01/2016 Authors: Serrano N; Moghanaki D; Asher D; Karlin J; Schutzer M; Chang M; Hagan MP
• Patient autonomy and shared decision making in the management of urethral cancer.
  Pract Radiat Oncol Volume: 6 Page(s): 66 - 70
  01/01/2016 Authors: Serrano N; Chang M; Leland Rogers C; Orton M; Mannino R; Grob M; Agarwal R; Moghanaki D
• Dose Response for Salvage Radiation Therapy After Radical Prostatectomy in Margin-Positive Prostate Cancer
  Volume: 93 Page(s): S132 - S133
  11/01/2015 Authors: Agrawal S; Pisansky TM; Hamstra DA; Liauw S; Koontz BF; Efstathiou JA; Michalski JM; Feng FY; Abramowitz MC; Pollack A
• Contemporary Update of a Multi-institutional Predictive Nomogram for Salvage Radiation Therapy After Prostatectomy
  Volume: 93 Page(s): S131 - S131
  11/01/2015 Authors: Tendulkar RD; Agrawal S; Efstathiou JA; Pisansky TM; Michalski JM; Koontz BF; Hamstra DA; Feng FY; Liauw S; Abramowitz MC
• Management of Metastatic Spinal Cord Compression Among Veterans Health Administration Radiation Oncologists
  Volume: 93 Page(s): E475 - E476
  11/01/2015 Authors: Gutt R; Malhotra S; Jolly S; Moghanaki D; Cheuk AV; Fosmire H; Kelly MD; Hoffman-Hogg L; Lutz S; Anscher MS
• Can Stereotactic Ablative Radiation Therapy (SABR) Improve Patient Selection for Lung Cancer Surgery and Reduce Perioperative Mortality?
  Volume: 93 Page(s): E409 - E409
  11/01/2015 Authors: Serrano N; Adams B; Szentpetery S; Rogers L; Chang MG; Moghanaki D
• Posttreatment Testosterone Levels Do Not Affect Rates of Biochemical Failure in Men Who Have Undergone Definitive Radiation for Prostate Cancer: Implications for Testosterone Replacement
  Volume: 93 Page(s): E197 - E197
  11/01/2015 Authors: Tennyson NB; Mukhopadhyay ND; Moghanaki D; Chang MG; Hagan MP
• The Cost Consequences of Multiparametric MRI-Based Image Surveillance for Gleason's Score 6 Prostate Cancer
  Volume: 93 Page(s): E191 - E191
  11/01/2015 Authors: Kalman NS; Hillner BE; Moghanaki D
• In Reply to Mell.
  Int J Radiat Oncol Biol Phys Volume: 93 Page(s): 468 - 469
  10/01/2015 Authors: Vapiwala N; Moghanaki D; Movsas B
• Improved Survival in Patients with Stage I-II NSCLC Treated with Surgery or Radiotherapy in the Department of Veterans Affairs
  Volume: 10 Page(s): S280 - S281
  09/01/2015 Authors: Salama JK; Williams CD; Moghanaki D; Kelley MJ
• Can Stereotactic Ablative Radiotherapy (SABR) Improve Patient Selection for Lung Cancer Surgery and Reduce Perioperative Mortality?
  Volume: 10 Page(s): S329 - S329
  09/01/2015 Authors: Serrano N; Adams B; Szentpetery S; Rogers CL; Chang M; Moghanaki D
• A review of rectal toxicity following permanent low dose-rate prostate brachytherapy and the potential value of biodegradable rectal spacers.
  Prostate Cancer Prostatic Dis Volume: 18 Page(s): 96 - 103
  06/01/2015 Authors: Schutzer ME; Orio PF; Biagioli MC; Asher DA; Lomas H; Moghanaki D
• Cultivating Tomorrow's Clinician Scientists: We Reap What We Sow.
  Int J Radiat Oncol Biol Phys Volume: 92 Page(s): 206 - 210
  06/01/2015 Authors: Vapiwala N; Moghanaki D; Movsas B
• Palliative Radiotherapy for the Management of Metastatic Cancer: Bone Metastases, Spinal Cord Compression, and Brain Metastases.
  Fed Pract Volume: 32 Page(s): 12S - 16S
  05/01/2015 Authors: Gutt R; Dawson G; Cheuk AV; Fosmire H; Moghanaki D; Kelly M; Jolly S
• Clinic offering affordable radiation therapy to increase access to care for patients enrolled in hospice.
  J Oncol Pract Volume: 10 Page(s): e390 - e395
  11/01/2014 Authors: Schuster JM; Smith TJ; Coyne PJ; Lutz S; Anscher MS; Moghanaki D
• Availability of single-fraction palliative radiotherapy for cancer patients receiving end-of-life care within the Veterans Healthcare Administration.
  J Palliat Med Volume: 17 Page(s): 1221 - 1225
  11/01/2014 Authors: Moghanaki D; Cheuk AV; Fosmire H; Anscher MS; Lutz ST; Hagan MP; Dawson GA; U.S. Veterans Healthcare Administration National Palliative Radiotherapy Taskforce
• A Compassionate Care Palliative Radiation Therapy Program for Cancer Patients Enrolled in Hospice: Offering Reduced-Cost Palliative Radiation Therapy in the Same Day as Evaluation
  Volume: 90 Page(s): S703 - S703
  09/01/2014 Authors: Schuster JM; Smith TJ; Lutz S; Coyne PJ; Mitch A; Moghanaki D
• Availability of Single-Fraction Palliative Radiation Therapy for Cancer Patients Receiving End-of-Life Care Within the Veterans Healthcare Administration
  Volume: 90 Page(s): S689 - S690
  09/01/2014 Authors: Moghanaki D; Cheuk AV; Fosmire HF; Lutz ST; Anscher MS; Hagan MP; Dawson GA
• The Emergence of New Late Radiation Toxicities Beyond the Traditional 5 Years of Follow-Up After Low-Dose-Rate Prostate Brachytherapy
  Volume: 90 Page(s): S456 - S457
  09/01/2014 Authors: Asher D; Moghanaki D; Serrano N; Karlin J; Schutzer M; Chang M; Hagan MP
• Long-Term Follow-Up After MRI-Directed Regional Salvage Brachytherapy for Locally Recurrent Adenocarcinoma of the Prostate
  Volume: 90 Page(s): S452 - S452
  09/01/2014 Authors: Urdaneta AI; Grob BM; Fatouros P; Moghanaki D; Yu J; Hagan M
• Availability of single-fraction palliative radiotherapy for cancer patients receiving end-of-life care within the Veterans Healthcare Administration.
  Volume: 32
  05/20/2014 Authors: Moghanaki D; Cheuk AV; Fosmire H; Anscher MS; Hagan MP; Lutz ST; Dawson GA
• Availability of Single Fraction Palliative Radiotherapy for Cancer Patients Receiving End-of-Life Care Within the Veterans Healthcare Administration
  Volume: 47 Page(s): 393 - 394
  02/01/2014 Authors: Moghanaki D; Cheuk A; Fosmire H; Dawson G; Anscher M; Lutz S
• Surgery versus SABR for NSCLC.
  Lancet Oncol Volume: 14 Page(s): e490 - e491
  11/01/2013 Authors: Moghanaki D; Karas T
• Identifying appropriate patients for early salvage radiotherapy after prostatectomy.
  J Urol Volume: 190 Page(s): 1410 - 1415
  10/01/2013 Authors: Karlin JD; Koontz BF; Freedland SJ; Moul JW; Grob BM; Wan W; Hagan MP; Anscher MS; Moghanaki D
• Short-term Androgen Deprivation Therapy Does Not Cause Long-term Testosterone Suppression or Increased Acute Side Effects in Patients Treated With Brachytherapy for Prostate Cancer
  Volume: 87 Page(s): S387 - S387
  10/01/2013 Authors: Tennyson NB; Mukhopadhyay N; Chang M; Moghanaki D; Hagan M
• An International Survey of Definitive SABR for Extracranial Limited Metastases
  Volume: 87 Page(s): S605 - S605
  10/01/2013 Authors: Lewis SL; Porceddu S; Hoskin P; Chmura S; Moghanaki D; Lo S; Palma D; Nakamura N; Salama J
• Prostate cancer: should men with metastases undergo radical prostatectomy?
  Nat Rev Urol Volume: 10 Page(s): 501 - 502
  09/01/2013 Authors: Moghanaki D; Anscher MS
• The value of an educational video before consultation with a radiation oncologist.
  J Cancer Educ Volume: 28 Page(s): 306 - 313
  06/01/2013 Authors: Matsuyama RK; Lyckholm LJ; Molisani A; Moghanaki D
• Re: Comparison of mortality outcomes after radical prostatectomy versus radiotherapy in patients with localized prostate cancer: a population-based analysis.
  Int J Urol Volume: 20 Page(s): 547 - 548
  05/01/2013 Authors: Moghanaki D; Freedland SJ; Anscher M
• Consultation and Delivery of Palliative Radiotherapy in a Single Day for Cancer Patients Enrolled in Hospice
  Volume: 45 Page(s): 451 - 452
  02/01/2013 Authors: Schuster J; Coyne P; Lutz S; Smith T; Anscher M; Moghanaki D
• Elective irradiation of pelvic lymph nodes during postprostatectomy salvage radiotherapy.
  Cancer Volume: 119 Page(s): 52 - 60
  01/01/2013 Authors: Moghanaki D; Koontz BF; Karlin JD; Wan W; Mukhopadhay N; Hagan MP; Anscher MS
• Contour Variability During Stereotactic Body Radiation Therapy (SBRT) Treatment Planning and the Effect of Physician Training
  Volume: 84 Page(s): S816 - S817
  11/01/2012 Authors: Orton MD; Weiss E; Chang MG; Moghanaki D; Roman N; Vera R; Nedelka M; Urdaneta A; Schuster J
• Significant Variation in Provider Discussion of Sexual Side Effects With Radiation Therapy Patients
  Volume: 84 Page(s): S210 - S210
  11/01/2012 Authors: Koontz BF; Flynn K; Reese JB; Urdeneta AI; Moghanaki D; Porter LS
• Elective Pelvic Lymph Node Irradiation, Without Androgen Deprivation Therapy, During Postprostatectomy Salvage Radiation Therapy
  Volume: 84 Page(s): S184 - S185
  11/01/2012 Authors: Moghanaki D; Koontz BF; Karlin JD; Wan W; Mukhopadhay ND; Hagan MP; Anscher MS
• Effect of Contour Variability on Dosimetric Tumor Coverage in Stereotactic Body Radiation Therapy (SBRT) for Stage I Lung Cancer
  Volume: 7 Page(s): S287 - S288
  09/01/2012 Authors: Orton MD; Chang MG; Moghanaki D; Neiderer K; Weiss E
• The United States Department of Veteran Affairs Healthcare System (VAHS) Provides a Suitable Multi-Institutional Setting for Phase III Randomized Trials of Stereotactic ABlative Radiotherapy (SABR) versus Lobectomy in Patients with Medically Operable Stage I Non-Small Cell Lung Cancer (NSCLC)
  Volume: 7 Page(s): S229 - S230
  09/01/2012 Authors: Adams BR; Moghanaki D; Wan W; Cassano AD; Szentpetery S
• Education level, not health literacy, associated with information needs for patients with cancer.
  Patient Educ Couns Volume: 85 Page(s): e229 - e236
  12/01/2011 Authors: Matsuyama RK; Wilson-Genderson M; Kuhn L; Moghanaki D; Vachhani H; Paasche-Orlow M
• Resection status, age and nodal involvement determine survival among patients receiving adjuvant chemoradiotherapy in pancreatic adenocarcinoma.
  JOP Volume: 12 Page(s): 438 - 444
  09/09/2011 Authors: Moghanaki D; Mick R; Furth EE; Sohal D; Salmon PM; Behbahani A; Morgans AK; Miller SM; Giantonio BJ; Whittington RW
• Exploring the Ideal Therapeutic Window for Successful Post-prostatectomy Salvage Radiotherapy (SRT) Below a Relapsed PSA of 1.0 ng/mL
  Volume: 81 Page(s): S74 - S74
  01/01/2011 Authors: Karlin JD; Koontz BF; Mukhopadhyay ND; Hagan MP; Anscher MS; Moghanaki D
• Patterns of Failure after Trimodality Therapy for Pancreatic and Duodenal Cancers
  Volume: 81 Page(s): S336 - S336
  01/01/2011 Authors: Miller SM; Ali AN; Mick R; Moghanaki D; Furth EE; Sohal D; Giantonio BJ; Plastaras JP
• Improved Biochemical Complete Response (BCR) and Biochemical Relapse-free Survival (RFS) with Whole Pelvis (WPRT) vs. Prostate Bed (PBRT) Radiotherapy in Patients Undergoing Salvage Treatment following Prostatectomy
  Volume: 78 Page(s): S30 - S31
  01/01/2010 Authors: Moghanaki D; Koontz B; Karlin J; Mukhopadhyay N; Yan B; Hagan M; Anscher M
• Improved patient and regimen selection in locally advanced rectal cancer: who, how, and what next?
  Clin Colorectal Cancer Volume: 8 Page(s): 194 - 199
  10/01/2009 Authors: Weiss J; Moghanaki D; Plastaras JP; Haller DG
• Denis Parsons Burkitt, FRSM, FRCS (Edinburgh): a passion for learning.
  J Pediatr Hematol Oncol Volume: 30 Page(s): 754 - 757
  10/01/2008 Authors: Moghanaki D
• Survival following resection of pancreatic cancers may not be affected by length of hospital stay or delay to initiating adjuvant chemoradiation (CRT)
  Volume: 26
  05/20/2008 Authors: Morgans A; Moghanaki D; Mick R; Furth EE; Salmon P; Behbehani A; Drebin J; Rosato EF; Whittington R; Giantonio BJ
• Survival following partial pancreatectomy and radiation for ampullary adenocarcinoma
  Volume: 26
  05/20/2008 Authors: Haynes JC; Moghanaki D; Morgans A; Salmon P; Furth EE; Giantonio BJ; Drebin J; Rosato EF; Whittington R; Metz JM
• Outcomes with postoperative chemoradiation (CRT) in patients (pts) with gross residual disease (R2) following surgical resection of pancreatic adenocarcinoma (PA)
  Volume: 26
  05/20/2008 Authors: Moghanaki D; Behbehani A; Morgans A; Salmon P; Furth EE; Sun W; Giantonio BJ; Metz JM; Rosato EF; Whittington R
• Differential roles of vascular endothelial growth factor receptors 1 and 2 in dendritic cell differentiation.
  J Immunol Volume: 174 Page(s): 215 - 222
  01/01/2005 Authors: Dikov MM; Ohm JE; Ray N; Tchekneva EE; Burlison J; Moghanaki D; Nadaf S; Carbone DP
• Polyomavirus middle T-induced mammary intraepithelial neoplasia outgrowths: single origin, divergent evolution, and multiple outcomes.
  Mol Cancer Ther Volume: 3 Page(s): 941 - 953
  08/01/2004 Authors: Maglione JE; McGoldrick ET; Young LJT; Namba R; Gregg JP; Liu L; Moghanaki D; Ellies LG; Borowsky AD; Cardiff RD
• Transgenic Polyoma middle-T mice model premalignant mammary disease.
  Cancer Res Volume: 61 Page(s): 8298 - 8305
  11/15/2001 Authors: Maglione JE; Moghanaki D; Young LJ; Manner CK; Ellies LG; Joseph SO; Nicholson B; Cardiff RD; MacLeod CL
• Genetically engineered mouse models of mammary intraepithelial neoplasia.
  J Mammary Gland Biol Neoplasia Volume: 5 Page(s): 421 - 437
  10/01/2000 Authors: Cardiff RD; Moghanaki D; Jensen RA
• The Quality of Peer-Reviewed Publications on Surgery for Early Stage Lung Cancer Within the Veterans Health Administration.
  Semin Thorac Cardiovasc Surg Volume: 32 Page(s): 1066 - 1073
  Authors: Welp AM; Abbott SE; Samson P; Cameron RB; Cornwell LD; Harpole D; Moghanaki D